Integra LifeSciences names Topaz Kirlew chief regulatory officer

Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation

IART

0.00
  • Integra LifeSciences named Topaz Kirlew corporate vice president, chief regulatory officer.
  • Kirlew will lead global regulatory affairs, overseeing strategy, compliance, submissions, transformation initiatives.
  • She previously served as interim regulatory leader, overseeing compliance, active submissions, risk mitigation.
  • Kirlew joined Integra in 2021; brings 35 years’ experience across regulatory affairs, quality, operations, clinical functions.
  • Her prior roles include Danaher, Apyx Medical, Bio-Tissue, University of Miami’s Diabetes Research Institute; began as a clinical laboratory scientist.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607020830PRIMZONEFULLFEED9755882) on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.